A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Investigational Treatment Gaining Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are encouraged to contact these accounts directly for supplier links, while also receiving discount codes.
Active Trade on Social Networks
Additionally, a robust market exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and claims of next-day UK delivery. Vendors promote the substance there before directing buyers to other platforms for purchases.
Understanding The Experimental Drug
This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could lead to users administering substances of unknown origin.
Some professionals said the popularity for retatrutide could be connected to the increasing price of approved weight loss treatments such as Mounjaro.
Legal Status and Implementation
Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, marketing, and customer regulations, risking fines, legal action or prison.
Service Response and Material Removal
Based on TikTok, the service has removed problematic content and prohibited related hashtags and query recommendations. The company stated it was dedicated to keeping the platform safe and investing in enhancing enforcement strategies.
Digital Marketplace Operations
Research also discovered communities with up to nine thousand participants marketing the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with numerous of users, populated with images of slimming results, positive reviews and detailed guides for preparing or injecting at home.
After moments of joining one group, a seller shared WhatsApp details, where the majority of transactions take place. The vendor provided an guidebook and guaranteed shipping within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about body mass, medical conditions or previous experience.
Product Details and Pricing
Inside these communities, posts show black plastic parcels with postal service stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or pre-filled pens usually priced at £160 for 20mg. When questioned how long a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for the messaging service said it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting materials they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not contain what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake injections are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.
Her team has previously seen individuals injured by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly investigational product not yet authorized … may subject patients to potentially serious medical dangers”.
